Ketamine clinics are popping up across the US, offering injections for many psychiatric disorders. They operate in a gray zone in which intravenous ketamine may be used for unapproved disorders – and don’t have to follow FDA guidance. Does Matthew Perry’s ketamine death suggest more oversight is indicated? Mark S Gold MD asks.


